Therefore, it appears that long-term supplementation is a required before effects become apparent
Anal Biochem 95:351358 Oyagbemi AA, Omobowale OT, Asenuga ER, Akinleye AS, Ogunsanwo RO, Saba AB (2016) Cyclophosphamide-induced hepatotoxicity in Wistar rats: the modulatory role of gallic acid as a hepatoprotective and chemopreventive phytochemical
Several patient characteristics may increase susceptibility to gastroparesis symptoms during GLP-1 therapy
Some botanical ingredients in GOLO may also affect gastrointestinal function, potentially compounding these side effects and reducing treatment tolerability
Common Reasons Non-Diabetic Patients Experience Low Blood Sugar Symptoms on GLP-1s While lab-confirmed hypoglycemia (low blood sugar) is rare, non-diabetic patients may experience symptoms in situations such as: Skipping meals or under-eating due to appetite suppression Very low-calorie dieting paired with GLP-1 use Rapid weight loss without adequate protein or carbohydrates Over-titration or incorrect dosing Reactive blood sugar drops after high-carb meals In these cases, symptoms often result from insufficient fuel rather than dangerously low glucose levels
At Preferred Dermatology, we understand that there is no single GLP1 option that is universally best for weight loss